Implementation of documented and written informed consent for clinical trials of communicable diseases: Lessons learned, barriers, solutions, future directions identified during the conduct of a COVID-19 clinical trial

BACKGROUND AND OBJECTIVE: The communicable nature of many infectious diseases, including SARS-CoV-2, creates challenges for implementing and obtaining regulatory-compliant written informed consent. The goal of this project was to identify and evaluate processes that address these barriers while main...

Descripción completa

Detalles Bibliográficos
Autores principales: Woods, Patricia, Flynn, Maura, Monach, Paul, Visnaw, Karen, Schiller, Sara, Holmberg, Erika, Leatherman, Sarah, Ferguson, Ryan, Branch-Elliman, Westyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234262/
https://www.ncbi.nlm.nih.gov/pubmed/34222708
http://dx.doi.org/10.1016/j.conctc.2021.100804

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234262/
https://www.ncbi.nlm.nih.gov/pubmed/34222708
http://dx.doi.org/10.1016/j.conctc.2021.100804

Ejemplares similares